Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Account Payables (2022)

Historic Change in Account Payables for Orchestra BioMed Holdings (OBIO) over the last 1 years, with Q4 2022 value amounting to $95369.0.

  • Orchestra BioMed Holdings' Change in Account Payables changed N/A to $95369.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $375542.0, marking a year-over-year change of. This contributed to the annual value of $375542.0 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q4 2022, Orchestra BioMed Holdings' Change in Account Payables is $95369.0.
  • Orchestra BioMed Holdings' Change in Account Payables' 5-year high stood at $110904.0 during Q3 2022, with a 5-year trough of $67050.0 in Q2 2022.